# Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod

> **NCT06860633** · PHASE4 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 20 (estimated)

## Conditions studied

- Myasthenia Gravis Crisis
- Myasthenia Gravis Exacerbations
- AChR Myasthenia Gravis

## Interventions

- **DRUG:** Efgartigimod

## Key facts

- **NCT ID:** NCT06860633
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860633, "Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06860633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*